ReviewFrontiers in oncology2019

Low-Dose vs. High-Dose Cisplatin: Lessons Learned From 59 Chemoradiotherapy Trials in Head and Neck Cancer.

Petr Szturz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.